The global antidiabetics market faces challenges related to medicine affordability and unequal access to treatment. The International Diabetes Federation highlights that a large number of people with diabetes remain undiagnosed, while access to appropriate therapies varies substantially across countries and healthcare systems. The antidiabetics market is projected to reach US$ 187.69 billion by...